JDD Spotlight The PROAK study evaluated real-world outcomes in patients with actinic keratosis reated with tirbanibulin 1% ointment over 24 weeks. Early improvements in quality of life were noted as…
From the Vault Do collagen supplements really work for skin? Collagen supplements are booming in the skincare world, but do they truly deliver on their promises? With little regulation around…
PSO Exciting: Clinical Pearls and Emerging Therapies For Psoriasis The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As…
Trending Article Alert Integrated skincare—the future of aesthetic outcomes? A roundtable, featured at the Thriving in Diversity webinar series, brought together leading dermatologists and cosmetic surgeons to discuss how integrated…
Did You Miss It? How does the roflumilast cream vehicle compare? For patients with inflammatory dermatologic conditions, a hydrating vehicle is key to improving the skin barrier without irritation. But…
From the Vault Isotretinoin remains the gold standard for treating severe nodulocystic acne, yet concerns about its potential psychiatric effects continue to spark debate. While high-quality studies have found no…
Featured Article Acanthosis nigricans disproportionately affects individuals with darker skin tones, yet no FDA-approved treatment currently exists. As the demand for effective therapies grows, the dermatology community faces a critical challenge:…